Annexon, Inc. (ANNX) vs Ginkgo Bioworks Holdings, Inc. (DNA)
Annexon, Inc. and Ginkgo Bioworks Holdings, Inc. are both Biotechnology companies. Annexon, Inc. and Ginkgo Bioworks Holdings, Inc. are of similar size ($720.4M and $683.6M). Annexon, Inc. has the higher net margin (0.00% vs −219.6%) and the higher return on invested capital (0.00% vs −161.9%). Across the 13 metrics below, Annexon, Inc. leads on 7 and Ginkgo Bioworks Holdings, Inc. on 6.
Valuation
Profitability
| Metric | ANNX | DNA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 68.04% | 65.16% |
| Operating margin | 0.00% | (231.13%) | 0.00% |
| Net margin | 0.00% | (219.60%) | 0.00% |
| Free cash flow margin | 0.00% | (131.57%) | 0.00% |
| Return on equity | (105.26%) | (56.29%) | (57.72%) |
| Return on assets | (79.38%) | (26.19%) | (49.22%) |
| Return on invested capital | 0.00% | (161.94%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack